Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20938724rdf:typepubmed:Citationlld:pubmed
pubmed-article:20938724lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:20938724lifeskim:mentionsumls-concept:C0007570lld:lifeskim
pubmed-article:20938724lifeskim:mentionsumls-concept:C0020840lld:lifeskim
pubmed-article:20938724pubmed:issue1lld:pubmed
pubmed-article:20938724pubmed:dateCreated2011-3-28lld:pubmed
pubmed-article:20938724pubmed:abstractTextIn celiac disease, gluten ingestion provokes small-bowel mucosal injury and production of IgA autoantibodies against transglutaminase 2 (TG2). It has been suggested that in celiac patients IgA could mediate the transepithelial passage of gluten peptides in a mechanism involving the transferrin receptor. As IgA1 with galactose-deficient O-linked glycans has elevated affinity for the transferrin receptor, we assessed whether total serum IgA1 and IgA1 anti-TG2 autoantibodies in celiac patients are aberrantly glycosylated. We report that males with celiac disease have higher total serum levels of galactose-deficient IgA1 than non-celiac males. Furthermore, O-glycans of the disease-specific TG2 IgA1 autoantibodies in celiac patients exhibited elevated galactose deficiency. A gluten-free diet had no effect on the total serum levels of galactose-deficient IgA1, whereas the amount of galactose-deficient anti-TG2 IgA1 decreased. Thus, the undergalactosylated IgA1 molecules are not pathognomonic for celiac disease, but galactose deficiency in IgA1 could be an aggravating factor.lld:pubmed
pubmed-article:20938724pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:languageenglld:pubmed
pubmed-article:20938724pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:citationSubsetIMlld:pubmed
pubmed-article:20938724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20938724pubmed:statusMEDLINElld:pubmed
pubmed-article:20938724pubmed:monthFeblld:pubmed
pubmed-article:20938724pubmed:issn1573-2592lld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:MäkiMarkkuMlld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:NovakJanJlld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:SuzukiHitoshi...lld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:KaukinenKatri...lld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:CollinPekkaPlld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:LindforsKatri...lld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:SaavalainenPä...lld:pubmed
pubmed-article:20938724pubmed:authorpubmed-author:KoskinenLotta...lld:pubmed
pubmed-article:20938724pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20938724pubmed:volume31lld:pubmed
pubmed-article:20938724pubmed:ownerNLMlld:pubmed
pubmed-article:20938724pubmed:authorsCompleteYlld:pubmed
pubmed-article:20938724pubmed:pagination74-9lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:meshHeadingpubmed-meshheading:20938724...lld:pubmed
pubmed-article:20938724pubmed:year2011lld:pubmed
pubmed-article:20938724pubmed:articleTitleGalactosylation of serum IgA1 O-glycans in celiac disease.lld:pubmed
pubmed-article:20938724pubmed:affiliationPediatric Research Center, University of Tampere and Tampere University Hospital, Finn-Medi 3, FIN-33014 Tampere, Finland. katri.lindfors@uta.filld:pubmed
pubmed-article:20938724pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20938724pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20938724pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed